ConductScience.org, home

Paper42657238

Cytokine-Driven Hyperinflammation in Long COVID: Mechanisms, Biomarkers, Complement Dysregulation, and Emerging Immunotherapies-A Narrative Review.

Obeagu EI. Health Sci Rep, 2026. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Cytokine-Driven Hyperinflammation in Long COVID: Mechanisms, Biomarkers, Complement Dysregulation, and Emerging Immunotherapies-A Narrative Review. Papers, record 42657238. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42657238

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cytokine-Driven Hyperinflammation in Long COVID: Mechanisms, Biomarkers, Complement Dysregulation, and Emerging Immunotherapies-A Narrative Review.
PubMed
Journal
Health Sci Rep
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-28
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Obeagu EIEmmanuel Ifeanyihttps://orcid.org/0000-0002-4538-0161

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134,124,322Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies.Regen Ther2021https://conductscience.org/library/papers/34124322PubMed
234,956,607Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm.Interface Focus2022https://conductscience.org/library/papers/34956607PubMed
340,110,334The dynamic role of soluble urokinase plasminogen activator receptor (suPAR) in monitoring coagulation dysfunction during COVID-19 progression: a review.Ann Med Surg (Lond)2025https://conductscience.org/library/papers/40110334PubMed
440,092,217Efficient Control of IL-6, CRP and Ferritin in COVID-19 Patients With Two Variants of Beta-1,3-1,6 Glucans in Combination: An Open-Label, Prospective, Randomised Clinical Trial.Glob Adv Integr Med Health2025https://conductscience.org/library/papers/40092217PubMed
537,427,016Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention.Pathog Immun2023https://conductscience.org/library/papers/37427016PubMed
632,412,405Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation.Eur J Rheumatol2020https://conductscience.org/library/papers/32412405PubMed
740,729,168COVID-19-Omics Report: From Individual Omics Approaches to Precision Medicine.Reports (MDPI)2023https://conductscience.org/library/papers/40729168PubMed
835,621,229The role of cytokines and their antagonists in the treatment of COVID-19 patients.Rev Med Virol2023https://conductscience.org/library/papers/35621229PubMed
939,359,765Impacts of COVID-19 on hemostasis: coagulation abnormalities and management perspectives.Ann Med Surg (Lond)2024https://conductscience.org/library/papers/39359765PubMed
1036,851,766Hyperinflammatory Response in COVID-19: A Systematic Review.Viruses2023https://conductscience.org/library/papers/36851766PubMed
1133,559,152Biomarker-Guided Individualization of Antibiotic Therapy.Clin Pharmacol Ther2021https://conductscience.org/library/papers/33559152PubMed
1238,543,226Advancing Precision Medicine: A Review of Innovative In Silico Approaches for Drug Development, Clinical Pharmacology and Personalized Healthcare.Pharmaceutics2024https://conductscience.org/library/papers/38543226PubMed
1335,208,467Cytokine Storm in COVID-19: Immunopathogenesis and Therapy.Medicina (Kaunas)2022https://conductscience.org/library/papers/35208467PubMed
1435,269,564COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.Int J Mol Sci2022https://conductscience.org/library/papers/35269564PubMed
1534,013,158Triggers, Timescales, and Treatments for Cytokine-Mediated Tissue Damage.Euro Med J Innov2021https://conductscience.org/library/papers/34013158PubMed
1637,419,534Postacute Sequelae of SARS-CoV-2: Musculoskeletal Conditions and Pain.Phys Med Rehabil Clin N Am2023https://conductscience.org/library/papers/37419534PubMed
1734,248,921Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms.Front Microbiol2021https://conductscience.org/library/papers/34248921PubMed
1839,861,166Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/39861166PubMed
1941,112,249Multi-omics and machine learning identify novel biomarkers and therapeutic targets of COVID-19.Front Immunol2025https://conductscience.org/library/papers/41112249PubMed
2038,359,836Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID.Med2024https://conductscience.org/library/papers/38359836PubMed

See all 54 references

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNG3,458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL1B3,553PubTator's text mininghttps://conductscience.org/library/genes/3553NCBI Gene
IL63,569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
TNF7,124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42657238

GET https://conductscience.org/api/papers/v1/42657238/references?page=2